| Unauthorized package |
1595617
|
ACTOVEGIN |
B06AB80 |
Deproteinised hemoderivative of calf blood |
solution for injection |
40mg 1ml 2ml 25TK |
FarmFirma Soteks, ZAO |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1096534
|
ACTOVEGIN |
B06AB80 |
Deproteinised hemoderivative of calf blood |
solution for injection |
80mg 2ml 2ml 25TK |
NYCOMED DAK |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1164574
|
ACTOVEGIN |
B06AB80 |
Deproteinised hemoderivative of calf blood |
solution for injection |
200mg 5ml 5ml 5TK |
Takeda Austria GmbH |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1227518
|
ACTOVEGIN |
B06AB80 |
Deproteinised hemoderivative of calf blood |
solution for injection |
80mg 2ml 2ml 5TK |
NYCOMED DAK |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1111622
|
ACTOVEGIN FORTE |
B06AB80 |
Deproteinised hemoderivative of calf blood |
tablet |
200mg 50TK |
Nycomed Austria GmbH |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1831441
|
ADAKVEO |
B06AX01 |
Crizanlizumab |
concentrate for solution for infusion |
10mg 1ml 10ml 1TK |
Novartis Europharm Limited |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1351392
|
BERINERT |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
500RÜ 1TK |
CSL Behring GmbH |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1836514
|
BERINERT IV |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
1500RÜ 1TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 3 ml |
11.07.2023 |
 |
|
|
Yes |
| Authorized package |
1836503
|
BERINERT IV |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection/infusion |
500RÜ 1TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 10 ml |
17.10.2023 |
|
|
|
Yes |
| Authorized package |
1853849
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
3000RÜ 20TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 6 ml |
|
|
|
|
Yes |
| Authorized package |
1853827
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
2000RÜ 20TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 4 ml |
|
|
|
|
Yes |
| Authorized package |
1853816
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
2000RÜ 5TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 4 ml |
|
|
|
|
Yes |
| Authorized package |
1836536
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
3000RÜ 1TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 6 ml |
|
|
|
|
Yes |
| Authorized package |
1853838
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
3000RÜ 5TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 6 ml |
|
|
|
|
Yes |
| Authorized package |
1836525
|
BERINERT SC |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
2000RÜ 1TK |
CSL Behring GmbH |
Prescription |
|
|
lahusti 4 ml |
|
|
|
|
Yes |
| Authorized package |
1533035
|
CINRYZE |
B06AC01 |
C1-inhibitor, plasma derived |
powder and solvent for solution for injection |
500RÜ 2TK |
Takeda Manufacturing Austria AG |
Prescription |
|
|
lahusti viaalis 5 ml |
14.11.2023 |
|
|
Yes |
Yes |
| Authorized package |
1523607
|
FIRAZYR |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
10mg 1ml 3ml 3TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1381632
|
FIRAZYR |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
10mg 1ml 3ml 1TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
30.08.2023 |
|
|
|
Yes |
| Authorized package |
1892628
|
HEMGENIX |
B06AX80 |
Etranacogene dezaparvovec |
concentrate for solution for infusion |
10ml 1TK |
CSL Behring GmbH |
Prescription |
|
|
|
|
|
|
Yes |
Yes |
| Unauthorized package |
1768710
|
HYALURONIDASE |
B06AA03 |
Hyaluronidase |
powder for solution for injection/infusion |
1500RÜ 10TK |
C P Pharmaceuticals Limited |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1309980
|
HYLASE "DESSAU" |
B06AA03 |
Hyaluronidase |
powder for solution for injection |
1500RÜ 10TK |
Riemser Arzneimittel AG |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1848753
|
HYLASE DESSAU |
B06AA03 |
Hyaluronidase |
powder for solution for injection |
150RÜ 10TK |
Riemser Pharma GmbH |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1857012
|
ICATIBANT ACCORD |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 1TK |
Accord Healthcare S.L.U. |
Prescription |
|
|
|
25.05.2022 |
|
|
|
Yes |
| Authorized package |
1857023
|
ICATIBANT ACCORD |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 3TK |
Accord Healthcare S.L.U. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1823341
|
ICATIBANT AUXILIA |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 3TK |
Auxilia Pharma OÜ |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1823330
|
ICATIBANT AUXILIA |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 1TK |
Auxilia Pharma OÜ |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1822924
|
ICATIBANT FRESENIUS |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 3TK |
Fresenius Kabi Polska Sp. z o.o. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1822913
|
ICATIBANT FRESENIUS |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
30mg 3ml 3ml 1TK |
Fresenius Kabi Polska Sp. z o.o. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1822957
|
ICATIBANT TEVA |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
10mg 1ml 3ml 3TK |
Teva B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1822946
|
ICATIBANT TEVA |
B06AC02 |
Icatibant |
solution for injection in pre-filled syringe |
10mg 1ml 3ml 1TK |
Teva B.V. |
Prescription |
|
|
|
01.09.2023 |
|
|
|
Yes |
| Unauthorized package |
1823138
|
LYDASA |
B06AA03 |
Hyaluronidase |
powder for solution for injection |
64RÜ 5TK |
Samson-Med OOO |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1547287
|
LYDASA |
B06AA03 |
Hyaluronidase |
powder for solution for injection |
64RÜ 10TK |
Mikrogen |
Prescription |
|
|
|
|
|
|
|
|
| Unauthorized package |
1480508
|
LYDASA-BIOPHARMA |
B06AA03 |
Hyaluronidase |
powder for solution for injection |
64RÜ 10TK |
Biopharma ZAO |
Prescription |
|
|
|
|
|
|
|
|
| Authorized package |
1227653
|
NORMOSANG |
B06AB01 |
Hemin |
concentrate for solution for infusion |
25mg 1ml 10ml 4TK |
Recordati Rare Diseases |
Prescription |
|
|
|
10.04.2023 |
|
|
Yes |
Yes |
| Authorized package |
1847448
|
ORLADEYO |
B06AC06 |
Berotralstat |
capsule, hard |
150mg 98TK |
BioCryst Ireland Limited |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1847437
|
ORLADEYO |
B06AC06 |
Berotralstat |
capsule, hard |
150mg 28TK |
BioCryst Ireland Limited |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1875999
|
OXBRYTA |
B06AX03 |
Voxelotor |
film-coated tablet |
500mg 90TK |
Pfizer Europe MA EEIG |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3039735
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
20mg 56TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3039555
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
5mg 56TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3039746
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
50mg 56TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3044720
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
5mg/20mg 7TK / 7TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3039757
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
20mg/50mg 7TK / 7TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3039566
|
PYRUKYND |
B06AX04 |
Mitapivat |
film-coated tablet |
5mg 7TK |
Agios Netherlands B.V. |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1736782
|
RUCONEST |
B06AC04 |
Conestat alfa |
powder and solvent for solution for injection |
2100ühik 1TK |
Pharming Group N.V. |
Prescription |
|
|
lahusti 20 ml |
|
|
|
Yes |
Yes |
| Authorized package |
1503683
|
RUCONEST |
B06AC04 |
Conestat alfa |
powder for solution for injection |
2100ühik 1TK |
Pharming Group N.V. |
Prescription |
|
|
|
15.12.2020 |
|
|
Yes |
Yes |
| Unauthorized package |
1797936
|
ZYNTEGLO |
B06AB82 |
CD34 + cells encoding beta-A-T87Q-globin gene, autologous |
dispersion for infusion |
20ml 1TK |
bluebird bio (Netherlands) B.V. |
Prescription |
|
|
|
|
|
|
Yes |
|
| Authorized package |
3046407
|
TAKHZYRO |
B06AC05 |
Lanadelumab |
solution for injection in pre-filled syringe |
300mg 2ml 2ml 6TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3050817
|
TAKHZYRO |
B06AC05 |
Lanadelumab |
solution for injection in pre-filled syringe |
150mg 1ml 1ml 2TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
3050806
|
TAKHZYRO |
B06AC05 |
Lanadelumab |
solution for injection in pre-filled syringe |
150mg 1ml 1ml 1TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
|
|
|
|
Yes |
| Authorized package |
1814048
|
TAKHZYRO |
B06AC05 |
Lanadelumab |
solution for injection |
300mg 2ml 2ml 6TK |
Takeda Pharmaceuticals International AG Ireland Branch |
Prescription |
|
|
|
|
|
|
|
Yes |